← Childhood acute lymphoblastic leukemia investigators

Amitkumar Mehta, MD

University of Alabama at Birmingham

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers in childhood acute lymphoblastic leukemia

PubMed author-name match

Trials

Studies that name Amitkumar Mehta, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:47 UTC. Open this list on ClinicalTrials.gov

Ph2
NCT04975555 · Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
University of Alabama at Birmingham · completed · Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.